Warfarin Treatment in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease Sins of Omission or Commission?

被引：12
|
作者：
Winkelmayer, Wolfgang C. [1 ,2 ]
Turakhia, Mintu P. [3 ,4 ]
机构：
[1] Stanford Univ, Sch Med, Div Nephrol, Dept Med, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA
[3] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Palo Alto, CA 94304 USA
[4] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2014年 / 311卷 / 09期
关键词：
ORAL ANTICOAGULATION; RISK-FACTORS; STROKE; PREVENTION; HEMORRHAGE; TRIAL;
D O I：
10.1001/jama.2014.1781
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：913 / 915
页数：3
相关论文
共 50 条
  • [31] Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease
    Qamar, Arman
    Bhatt, Deepak L.
    CIRCULATION, 2016, 133 (15) : 1512 - 1515
  • [32] Management of patients with atrial fibrillation and chronic kidney disease in light of the latest guidelines
    Mlodawska, Elzbieta
    Tomaszuk-Kazberuk, Anna
    Lopatowska, Paulina
    Musial, Wlodzimierz J.
    Malyszko, Jolanta
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2016, 126 (05): : 353 - 362
  • [33] Prevalence of Atrial Fibrillation and Its Predictors in Nondialysis Patients with Chronic Kidney Disease
    Ananthapanyasut, Wanwarat
    Napan, Sirikarn
    Rudolph, Earl H.
    Harindhanavudhi, Tasma
    Ayash, Husam
    Guglielmi, Kelly E.
    Lerma, Edgar V.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (02): : 173 - 181
  • [34] Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease
    Hart, Robert G.
    Eikelboom, John W.
    Brimble, K. Scott
    McMurtry, M. Sean
    Ingram, Alistair J.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (07) : S71 - S78
  • [35] Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
    Lee, Kuo-Hua
    Ou, Shuo-Ming
    Chu, Yuan-Chia
    Lin, Yao-Ping
    Tsai, Ming-Tsun
    Tarng, Der-Cherng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [36] The Quandary of Oral Anticoagulation in Patients With Atrial Fibrillation and Chronic Kidney Disease
    Schwartzenberg, Shmuel
    Lev, Eli I.
    Sagie, Alexander
    Korzets, Asher
    Kornowski, Ran
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (03) : 477 - 482
  • [37] Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum
    Mukhin, N. A.
    Glybochko, P. V.
    Svistunov, A. A.
    Fomin, V. V.
    Kiyakbaev, G. G.
    TERAPEVTICHESKII ARKHIV, 2016, 88 (06) : 4 - 8
  • [38] Effects of Prevalent and Incident Chronic Kidney Disease on Cardiovascular Events in Patients with Atrial Fibrillation
    Lin, Hsuan-Yu
    Kor, Chew-Teng
    Hsieh, Yao-Peng
    Chiu, Ping-Fang
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
  • [39] Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoina Hemodialysis
    Coleman, Craig, I
    Kreutz, Reinhold
    Sood, Nitesh A.
    Bunz, Thomas J.
    Eriksson, Daniel
    Meinecke, Anna-Katharina
    Baker, William L.
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (09) : 1078 - 1083
  • [40] Warfarin for stroke prevention still underused in atrial fibrillation - Patterns of omission
    Cohen, N
    Almoznino-Sarafian, D
    Alon, I
    Gorelik, O
    Koopfer, M
    Chachashvily, S
    Shteinshnaider, M
    Litvinjuk, V
    Modai, D
    STROKE, 2000, 31 (06) : 1217 - 1222
12345